3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Antibody is a Rabbit polyclonal antibody for the detection of Human 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR).
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Size 1 | 50 µg |
Size 2 | 100 µg |
Form | Liquid |
Tested Applications | ELISA, WB, IHC |
Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
Availability | Shipped within 5-12 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | P04035 |
Gene ID | 3156 |
NCBI Accession | NP_000850.1 |
Background | Antibody anti-HMGCR |
Status | RUO |
Descripción
Related Products

Human HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase) ELISA Kit
Ver Producto
HMGCR antibody
HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Ver Producto
HMGCR antibody
HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Ver Producto